Atlas Trials

Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Clinical trial NCT00028899 · COMPLETED

Trial details

NCT number
NCT00028899
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic Syndromes
Start date
2002-07-01
Primary completion
2006-09-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.